View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Cerba Research

Laboratory Testing and Project Management for Clinical Trials

Cerba Research provides laboratory services for clinical trials to support areas such as medical testing, patient stratification and monitoring.

Industriepark 3,
9052 Ghent,

Cerba Research provides laboratory services for clinical trials to support areas such as medical testing, patient stratification and monitoring.

The company uses state-of-the-art technologies to support research and development (R&D) processes in areas such as oncology, immunology, genetics, microbiology and pathology.

Cerba Research has a global network of laboratories in the Americas, Europe, Africa and the Asia-Pacific (APAC) regions.

Barc Lab provides routine and specialised central lab services to the pharmaceutical and biotech industries.
The company supports research in oncology, immunology, genetics, microbiology and clinical pathology.
The company's services include immunoprofiling and biomarker analysis.
Barc Lab has an extensive network of laboratories throughout Europe.
Barc Lab is based in Ghent, Belgium.

Pharmaceutical and biotech testing for clinical trials

Cerba Research offers customised testing services throughout clinical studies, from set-up to delivery. The company’s team of experts tests patient samples quickly and accurately, allowing pharmaceutical and biotechnology clients to focus on therapy development.

The company understands client requirements and is experienced with flow cytometry, histopathology, pharmacokinetics (PK) and biomarkers, as well as genetics and microbiology.

Project management and logistics for clinical studies

Cerba Research has more than 35 years of experience with handling complex logistical trials. The company organises procedures for studies in a wide range of therapeutic areas, including oncology, non-alcoholic steatohepatitis (NASH), infections, neurology and rare diseases.

The company’s project management services support open and pro-active communication between clinics while data is collected and recorded into a single global study database.

Cerba Research manufacturers kits that contain the materials required to obtain blood, urine, stool, cerebral spinal fluid (CSF) and bone marrow aspirate samples from patients. These kits follow Integrated Approaches to Testing and Assessment (IATA) regulations and include barcoded labels to facilitate sample tracking.

Custom assay development for precision medicine

Cerba Research recognises the importance of sharing scientific insights and implementing novel tests and customised assays.

The company helps develop precision medicine to provide the industry with customised solutions such as:

  • Flexible solutions for complex flow cytometry needs
  • Comprehensive cytokine profiling by selecting a panel of interest
  • Immunoprofiling and biomarker analysis for patient inclusion and monitoring
  • Molecular diagnostic tools
  • High-level bioanalytical support in method development, validation and sample analysis of PK, pharmacodynamics (PD) and immunogenicity assays
  • Technology transfers of assays

International network of routine medical laboratories

BARC is supported by the medical biological and diagnostic network Cerba Healthcare. Headquartered in Paris, Cerba HealthCare was founded in 1967. It comprises more than 450 routine medical labs, 150 sampling centres and additional facilities that specialise in clinical pathology, veterinary biology and genetics.

Cerba HealthCare has more than 6,300 collaborators to provide high-quality healthcare services to patients, physicians and biopharmaceutical companies. This network ensures that patients benefit from proximity, quality and innovative biology.

Expansion of US Facility: Increased Capacity & Testing Capabilities

We reached an essential milestone in our company history in July, completing our US expansion. Leaning on our values of courage, innovation, and commitment, our increased capacity and expanded service offer enables us to continue growing our operational and scientific teams to support client needs.

30 July 2021

Cerba Research Awarded NIH Contract for Central Lab Services

Cerba Research today announced it was awarded a five-year contract for Clinical Central Laboratory Services from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).

27 July 2021

Covid-19: Institut Imagine and Cerba HealthCare are Partnering to Test for Patients Likely to Develop Severe Symptoms

In 2020, researchers at Inserm, Université de Paris, and Assistance Publique–Hôpitaux de Paris (AP- HP), in collaboration with the university hospital organisation Institut Imagine (Hôpital Necker-Enfants malades AP-HP), which has been granted 'Institut Carnot' certification through the Rockefeller University and the Howard Hughes Medical Institute in New York, identified the leading genetic and immunological causes responsible for at least 15% of serious forms of Covid-19.

30 April 2021


Industriepark 3
9052 Ghent

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology